154 results
8-K
EX-3.1
VNDA
Vanda Pharmaceuticals Inc
15 Dec 23
Amendments to Articles of Incorporation or Bylaws
4:15pm
before the meeting date: (1) on a reasonably accessible electronic network, provided that the information required to gain access to such list
8-K
EX-99.1
VNDA
Vanda Pharmaceuticals Inc
7 Dec 23
Entry into a Material Definitive Agreement
5:19pm
.
“The acquisition of Ponvory is a significant milestone for Vanda, as it expands our commercial portfolio and gives us access to a versatile immune
8-K
EX-99.1
66te8orj7vy3rilb
2 Nov 22
Vanda Pharmaceuticals Reports Third Quarter 2022 Financial Results
4:08pm
8-K
EX-99.1
d0wzx8v8
3 Aug 22
Vanda Pharmaceuticals Reports Second Quarter 2022 Financial Results
4:12pm
8-K
EX-99.1
ujyzzhyl
5 May 22
Vanda Pharmaceuticals Reports First Quarter 2022 Financial Results
12:00am
8-K
EX-99.1
1pwvb
4 Feb 22
Vanda Pharmaceuticals Reports Results from the Phase III Study of Tradipitant in Gastroparesis
7:07am